Obviously some have had enough and are out (most likely minor fund managers who have a different investment horizon etc).
Well I'll be buying a few more Monday.
Not because of what Shuster is saying ..but because I agree with the fundamentals of the company
His right in what he saying and I think someday (short term) Vinn will be "vindicated" about the shenanigans that have been going on.
The OSIRIS deal is yet to play out (particularly Crohns).
The JCR Pharma GVHD approval is yet to play out.
The MPC Japan Program is yet to play out.
Ange, see ASX release 31/10 re product filing.
..."In an announcement to the Tokyo Securities Exchange on 24 October, JCR President and CEO Shin
Ashida said the company intends to file for product regulatory approval in Japan for JR-031 during
the fiscal year ending March 2014. If the filing is successful, JR-031 would be the first allogeneic
cell-based product approved in Japan"...
Like TEVA will cannot make JCR update the market.. but unlike TEVA I dont think it will drag out to long (we are the Gorilla in this arrangement).
Good weekend to all.
michael schusfer has replied, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |